Is it safe to prescribe amoxicillin to an adult on low‑dose weekly methotrexate (10‑20 mg for rheumatoid arthritis or psoriasis), and what monitoring (liver and renal function) is required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin with Methotrexate: Safety and Monitoring

Amoxicillin can be prescribed to adults on low-dose weekly methotrexate (10-20 mg for rheumatoid arthritis or psoriasis), but requires heightened vigilance because penicillins reduce renal clearance of methotrexate and increase the risk of hematologic and gastrointestinal toxicity. 1

Mechanism of Drug Interaction

  • Penicillins, including amoxicillin, reduce the renal tubular secretion of methotrexate, leading to elevated serum methotrexate concentrations and increased risk of bone marrow suppression and gastrointestinal toxicity. 1
  • This interaction has been documented with both high-dose and low-dose methotrexate regimens, making it relevant for rheumatoid arthritis and psoriasis patients. 1
  • The risk is particularly elevated in patients with pre-existing renal impairment, as methotrexate is 85% renally excreted. 2

Clinical Decision Algorithm

When prescribing amoxicillin to a patient on methotrexate, follow this approach:

Step 1: Assess Patient Risk Factors

  • High-risk patients include those with renal insufficiency (creatinine clearance <60 mL/min), advanced age (>70 years), lack of folate supplementation, or hypoalbuminemia. 2, 3
  • Patients with diabetes, obesity, or concurrent NSAID use face additional risk. 4, 2

Step 2: Consider Alternative Antibiotics

  • For high-risk patients, consider non-penicillin antibiotics that do not compete for renal tubular secretion. 3
  • Avoid trimethoprim-sulfamethoxazole entirely, as it causes severe bone marrow suppression by inhibiting folate utilization. 2, 3

Step 3: If Amoxicillin is Necessary

  • Hold the weekly methotrexate dose during the antibiotic course and for 1-2 weeks afterward. 3
  • Ensure the patient is taking folic acid supplementation (1-5 mg daily, except on methotrexate day). 4, 2

Step 4: Enhanced Monitoring Protocol

  • Obtain complete blood count with differential before starting amoxicillin and 7-10 days after completing the antibiotic course. 4, 3
  • Withhold methotrexate if white blood cells <3.5×10⁹/L, neutrophils <2×10⁹/L, or platelets <100×10⁹/L. 2, 3
  • Check renal function (BUN, creatinine) before and after the antibiotic course, particularly in elderly patients or those with baseline renal impairment. 4, 3

Specific Monitoring Requirements

Hematologic Monitoring

  • The most critical toxicity to monitor is myelosuppression, which accounts for the majority of methotrexate-associated fatalities. 2
  • Symptoms requiring immediate evaluation include fever, sore throat, mouth ulcers, unexplained bruising, or unusual fatigue. 4, 2
  • If severe neutropenia (<1×10⁹/L) develops, administer filgrastim (G-CSF) 5 µg/kg subcutaneously daily and consider leucovorin rescue. 2, 3

Hepatic Monitoring

  • Check liver function tests (ALT, AST, alkaline phosphatase, albumin) if the antibiotic course exceeds 7-10 days or if the patient has hepatotoxicity risk factors. 4
  • Stop methotrexate if transaminases exceed 2× the upper limit of normal on repeat testing. 2, 3
  • Liver function abnormalities can be transitory and may normalize without permanently discontinuing methotrexate. 2

Renal Monitoring

  • Obtain serum creatinine and calculate creatinine clearance before prescribing amoxicillin, especially in elderly patients or those with decreased muscle mass. 4, 3
  • Patients with significant renal impairment are at risk even after single doses of methotrexate. 4
  • Consider dose reduction or temporary discontinuation of methotrexate if creatinine clearance is <60 mL/min. 4, 3

Critical Patient Education

  • Instruct patients to seek urgent medical attention if they develop fever, mouth ulcers, unusual bruising or bleeding, severe nausea/vomiting, or shortness of breath during or after antibiotic therapy. 4, 2
  • Emphasize that methotrexate is taken once weekly, not daily, to prevent dosing errors that could compound toxicity risk. 4, 1
  • Confirm the patient is taking folic acid supplementation daily (except on methotrexate day) to reduce toxicity risk. 4, 2

Common Pitfalls to Avoid

  • Do not assume low-dose methotrexate (10-20 mg weekly) is safe from drug interactions—penicillins increase toxicity at all dose levels. 1
  • Do not continue methotrexate during the antibiotic course in high-risk patients—holding the dose is safer than attempting to monitor through the interaction. 3
  • Do not delay leucovorin administration if toxicity is suspected—efficacy diminishes dramatically after 24 hours. 2
  • Do not prescribe trimethoprim-sulfamethoxazole as an alternative—it causes more severe methotrexate toxicity than penicillins. 2, 3

When to Resume Methotrexate

  • Resume methotrexate only after confirming normal complete blood count, renal function, and absence of infection. 2, 3
  • If any hematologic parameters remain abnormal, continue holding methotrexate and recheck weekly until recovery. 4, 3
  • Consider reducing the methotrexate dose by 25-50% for the first dose after resumption in high-risk patients. 4

References

Guideline

Management of Methotrexate Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Monitoring for Methotrexate Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.